Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1507.25-9.95 (-0.66 %)
PREV CLOSE () 1517.20
OPEN PRICE () 1514.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22157
TODAY'S LOW / HIGH ()1498.35 1515.00
52 WK LOW / HIGH ()1310.05 1672.2
NSE1508.00-9.4 (-0.62 %)
PREV CLOSE() 1517.40
OPEN PRICE () 1505.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 855508
TODAY'S LOW / HIGH() 1498.00 1515.50
52 WK LOW / HIGH ()1335 1673
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
11Dec Cipla moves up on launching ‘Yurpeak’
Cipla is currently trading at Rs. 1498.40, up by 9.25 points or 0.62% fr..
10Dec Cipla launches ‘Yurpeak’
Cipla has launched Yurpeak (tirzepatide), a one-weekly injectable therap..
05Dec Cipla completes acquisition of 100% st
Cipla has completed acquisition of 100% stake in Inzpera Healthsciences..
05Dec Cipla gains on completing acquisition
Cipla is currently trading at Rs. 1524.60, up by 3.40 points or 0.22% fr..
04Dec Cipla launches therapy for Knee Osteoa
Cipla has partnered with Stempeutics Research to launch Ciplostem, a the..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit12105.351576.5
Gross Profit 16333.4 64688.2
Operating Profit 17772.967631.6
Net Sales 52257.2190448.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Neuland Laboratories (BSE)
 16421.90 (2.15%)
M.Cap ( in Cr)
21069.12
Procter&Gamble Healt (BSE)
 5675.85 (1.74%)
M.Cap ( in Cr)
9421.56
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2372.25 (2.78%)
M.Cap ( in Cr)
3923.47
Shareholding Pattern
PROMOTERS 29.21%
MUTUAL FUNDS/UTI 20.23%
NON-INSTITUTION 16%
FI/BANKS/INSURANCE 8.27%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI